Literature DB >> 12955720

Mutational analysis of the AGL gene: five novel mutations in GSD III patients.

S Lucchiari1, M A Donati, D Melis, M Filocamo, R Parini, N Bresolin, G P Comi.   

Abstract

Total or partial lack of glycogen debranching enzyme (GDE or AGL, amylo-1,6-glucosidase, 4-alpha-glucanotransferase) is responsible for Glycogen Storage Disease type III (GSDIII), a rare autosomal recessive disorder of glycogen metabolism. The clinical and biochemical features of GSDIII subjects are quite heterogeneous, and this mirrors the genotype-phenotype heterogeneity among patients. In this paper, we report the molecular characterisation of five unrelated subjects, four Italian and one Tunisian. The following new mutations are described and confirm the genetic heterogeneity of this disease: p.R864X, p.R428K, c.3911 insA, p.G1087R and c.3512_3549dup+c.3512_3519del. The functional relevance of these mutations is discussed on the basis of the recently acquired knowledge about the boundaries and structures of the two catalytic domains. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955720     DOI: 10.1002/humu.9177

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

1.  Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.

Authors:  Yoriko Endo; Asako Horinishi; Matthias Vorgerd; Yoshiko Aoyama; Tetsu Ebara; Toshio Murase; Masato Odawara; Teodor Podskarbi; Yoon S Shin; Minoru Okubo
Journal:  J Hum Genet       Date:  2006-09-19       Impact factor: 3.172

2.  [Polyglycosan body myopathy].

Authors:  M Jeub; K Kappes-Horn; C Kornblum; D Fischer
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

3.  Markedly elevated serum transaminases in glycogen storage disease type III.

Authors:  Christine Karwowski; Csaba Galambos; David Finegold; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-05       Impact factor: 2.839

4.  Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III.

Authors:  Faten Ben Rhouma; Hatem Azzouz; François M Petit; Mariem Ben Khelifa; Amel Ben Chehida; Fehmi Nasrallah; Frédéric Parisot; Khaled Lasram; Rym Kefi; Yosra Bouyacoub; Lilia Romdhane; Christiane Baussan; Naziha Kaabachi; Marie-Françoise Ben Dridi; Neji Tebib; Sonia Abdelhak
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

5.  A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III.

Authors:  Ghada Hijazi; Anna Paschall; Sarah P Young; Brian Smith; Laura E Case; Tracy Boggs; Sathya Amarasekara; Stephanie L Austin; Surekha Pendyal; Areeg El-Gharbawy; Kristen L Deak; Andrew J Muir; Priya S Kishnani
Journal:  Mol Genet Metab Rep       Date:  2021-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.